We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 1113 (+2)

2% more funds holding

Funds holding: 283288 (+5)

0.07% more ownership

Funds ownership: 94.92%94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M
Name Holding Trade Value Shares
Change
Change in
Stake
GH
201
GAM Holding
Switzerland
$275K +$278K +3,000 New
KAS
202
Kestra Advisory Services
Texas
$263K +$6.31K +68 +2%
GCM
203
Greenland Capital Management
New York
$255K +$257K +2,775 New
SAM
204
Securian Asset Management
Minnesota
$235K -$9.28K -100 -4%
Prudential Financial
205
Prudential Financial
New Jersey
$233K -$19K -205 -7%
IFG
206
Independent Financial Group
California
$230K
MSRPS
207
Maryland State Retirement & Pension System
Maryland
$224K
TSS
208
Two Sigma Securities
New York
$212K +$215K +2,314 New
CM
209
Capula Management
Cayman Islands
$206K -$215K -2,312 -51%
AI
210
Atria Investments
North Carolina
$201K +$203K +2,190 New
Carson Wealth (CWM LLC)
211
Carson Wealth (CWM LLC)
Nebraska
$176K -$68.5K -738 -28%
Deutsche Bank
212
Deutsche Bank
Germany
$168K -$14.5M -156,108 -99%
Mirae Asset Global ETFs Holdings
213
Mirae Asset Global ETFs Holdings
Hong Kong
$168K +$170K +1,829 New
CTC
214
Cetera Trust Company
Minnesota
$166K
Russell Investments Group
215
Russell Investments Group
United Kingdom
$140K -$2.6K -28 -2%
AAM
216
Advisors Asset Management
Colorado
$140K -$47.3K -510 -25%
Osaic Holdings
217
Osaic Holdings
Arizona
$138K -$36.7K -396 -21%
S
218
SignatureFD
Georgia
$104K +$49.2K +530 +88%
C
219
Covestor
United Kingdom
$72K
QCG
220
Quadrant Capital Group
Ohio
$67.2K +$10.7K +115 +19%
HHGC
221
Hunting Hill Global Capital
New York
$65.5K -$195K -2,102 -75%
IC
222
Innealta Capital
Texas
$64.4K +$65K +701 New
RAM
223
Riggs Asset Management
Pennsylvania
$34.3K
LC
224
Lindbrook Capital
California
$29.7K +$9.09K +98 +43%
Fifth Third Bancorp
225
Fifth Third Bancorp
Ohio
$29.1K +$2.69K +29 +10%

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.